⟵ Back to Search Results
BGB-A317-307

Completed

A Study of Tislelizumab in Combination With Chemotherapy Versus Chemotherapy in Advanced Lung Cancer

Beigene Study ID info

BGB-A317-307

ClinicalTrials.gov ID info

NCT03594747

China Drug Trials ID info

CTR20180292

Study Overview

Sex: All

Age: 18 Years / 75 Years

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: All

Age: 18 Years / 75 Years

Study Documents

Study Protocol Statistical Analysis Plan